Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Posts
These Are This Week’s Top Performers as Bitcoin Settles at $91K: Weekend Watch
Bitcoin’s rather dull price actions over the weekend continue as the asset remains sideways at around $91,000, but…
POPCAT surges 30% amid Binance news, massive whale buy
The Solana-based meme coin Popcat exploded by more than 30%, leading the top-performing coins after a major listing…
Julian Assange Is Now Free: Here’s What He Believes About Bitcoin
Free speech champions across the world celebrated earlier this week as Julian Assange – founder of WikiLeaks –…